Table 1.

List of primers used in this study.

Gene	Forward Primer	Reverse Primer	Accession no
EF-1α	GATCCAGAAGGAGGTCACCA	TTACGTTCGACCTTCCATCC	AF498320
APRIL	CACAGACATACACAATGGAATGGAA	TGTGATGACAGAGGAACAAGATGAA	EF451543.1
BAFF	ATGTTTGATGCTTATTCTGGCAGG T	TGGGACTGTGTCTTGACTGTGTGTA	DQ218467
BALM	TGGAGGTACAGTAGTTCAGCAGTCG	ACTATCCAAGGAATCACCGTCACAT	NM_001124566
Batf3	CACAGAGAGCAGATGAGTTGCATAA	TTGCTCCTCAGACAGAAACTGTACC	CDQ67442.1
CCR7	TTCACTGATTACCCCACAGACAATA	AAGCAGATGAGGGAGTAAAAGGTG	JX982103
CD3	CCTGATTGGAGTAGCTGTCTAC	GCTGTACTCAGATCTGTCCATGC	XM_021582112
CD8β	GTTCAAGGCCAGTAAAAGGGACAT	GCCTCCACAACTCGTTCTCTTTCT	NM_001124008.1
CD11b	GAAATTCACTGGGGATAGAGAAACAG	CTACTCCAACTCCTGTCCCTATTATC	AM713180.2
CD80/86	GTGTTTCCTGGTTCTGGTATCTA	AACTTGCTGCTCCCTTTCCTC	FJ467621
CD83	GCTGTTGATAGCGGGAGGTA	TGTGGACTCAAGGCAATCTG	AY263793.1
CD103	AGGAGTGATCTTAAAACACCCCAAG	TGGCAGACACAACACTGTAACCTAA	CDQ67442.1
CD141	CAGAATTCAGCAACTGGAAAGACAA	ACTTTTTCCTGACAAGGTCGTTCTG	KP203844
DC-SIGN	GAGAAGGAAGGGGATTGGAG	CCCATGTGATCCTCCTGACT	NM_001124633
IFN-γ	GAAGGCTCTGTCCGAGTTCA	TGTGTGATTTGAGCCTCTGG	NM_001124620
IRF8	CCGAGGAGGAGCAGAAGAGTAAAAG	GCGGCATTGAAAGAACCCAT	AJ829674
MHC-I	GACAGTCCGTCCCTCAGTGT	CTGGAAGGTTCCATCATCGT	AF115522
MHC-II	ACACCCTTATCTGCCACGTC	TCTGGGGTGAAGCTCAGACT	AF296384
TCRα	ACGCACTTGGAATTATTCAACAAGA	GCTTCACATTTCTCTGAACCACCTA	AAA98477.1
TLR1	CAGACGCCCTGTTGATGTT C	CCTTCACAAGTTCCACCACG	NM_001166101
TLR2	GATCCAGAGCAACACTCTCAACAT	CTCCAGACCATGAAGTTGACAAAC	XM_021578334
TLR3	AGCCCTTTGCTGCCTTACAGAG	GTCTTCAGGTCATTTTTGGACACG	NM_001124578
TLR5	TTGACTTATCTTCCAACGGATTCA	CTTTGAAATTGCTGAAACCAAATG	NM_001124208
TLR7	TACAGCTTGGTAACATGACTCTCC	CAACTCTCTGAGACTTGTCGGTAA	GQ422119
TLR8a	CATCTATGTTCTCATCCAGCAACC	GGTCCCCCTAATAGACAACCTCTT	GQ422120
TLR9	TCTTCATAGAGCTGAAGAGGCCTCA	GTTCCCACTGAGGAGAAGTGTTTT	NM_001129991
TLR22	TGGACAATGACGCTCTTTTACC	GAGCTGATGGTTGCAATGAGG	NM_001124412